RCKT

ROCKET PHARMACEUTICALS INC

Healthcare | Micro Cap

-$0.38

EPS Forecast

$0.77

Revenue Forecast

Announcing earnings for the quarter ending 2026-09-30 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.38

Revenue Forecast:

$0.77

EPS Surprise Forecast:

$0.010

Revenue Surprise Forecast:

-$1

Post-release price volatility - High

Post-release Overnight Move:

±8.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

57%

Probability of beating revenue consensus:

45%

Probability of beating both EPS & revs consensus:

31%

Probability of missing both EPS & revs consensus:

29%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

1.23

Earnings volatility

EPS standard deviation:

$0.14

Revenue standard deviation:

$10

As % of share price:

5.19% EXTREME UNCERTAINTY

As % of market cap:

3.47% VERY HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.22

Revenue 95th %ile:

$12

EPS 75th %ile:

-$0.33

Revenue 75th %ile:

$4

EPS 25th %ile:

-$0.42

Revenue 25th %ile:

-$2

EPS 5th %ile:

-$0.55

Revenue 5th %ile:

-$9

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

35% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

53% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$39

Bid-ask per Share:

$0.01